Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 7/20 | 0.68 |
| ▸ | DPP4 | P27487 | 7/20 | 0.68 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.52 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.52 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.40 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.40 |
| ▸ | PDCD1 | Q15116 | 5/20 | 0.39 |
| ▸ | CD274 | Q9NZQ7 | 5/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29566034 | 0.86 | ANPEP (0.68) | ANPEPDPP4NR1H2NR1H3PDCD1 | |
| SCHEMBL173289 | 0.81 | ANPEP (1.00) | ANPEPDPP4NR1H2NR1H3 | |
| SCHEMBL13171786 | 0.80 | ANPEP (0.71) | ANPEPDPP4NR1H2NR1H3 | |
| SCHEMBL29366407 | 0.78 | DPP4 (0.78) | ANPEPDPP4NR1H2NR1H3KMT2A | |
| SCHEMBL2820118 | 0.78 | DPP4 (0.78) | ANPEPDPP4NR1H2NR1H3KMT2A | |
| SCHEMBL2818285 | 0.78 | ANPEP (1.00) | ANPEPDPP4NR1H2NR1H3KMT2A | |
| SCHEMBL9812636 | 0.78 | ANPEP (0.69) | ANPEPDPP4NR1H2NR1H3 | |
| SCHEMBL30278883 | 0.78 | ANPEP (0.68) | ANPEPDPP4NR1H2NR1H3KMT2A | |
| SCHEMBL30954668 | 0.77 | ANPEP (0.67) | ANPEPDPP4NR1H2NR1H3GABRA1 | |
| SCHEMBL17531021 | 0.77 | ANPEP (0.67) | ANPEPDPP4NR1H2NR1H3GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022192139-A1 | AURORA KINASE B INHIBITORS FOR USE FOR TREATING CANCER | ASTRAZENECA AB (SE) | 2022-09-15 | — | — | WO | claimed |
| EP-4451389-A1 | POSITIVE ELECTRODE MATERIAL COMPOSITION AND PREPARATION METHOD THEREFOR, POSITIVE ELECTRODE SHEET COMPRISING POSITIVE ELECTRODE MATERIAL COMPOSITION, SECONDARY BATTERY, AND ELECTRICAL DEVICE | Contemporary Amperex Technology (Hong Kong) Limited (HK) | 2024-10-23 | — | — | EP | disclosed |